Hansen has announced the completion of the world’s first clinical procedure using the Magellan Robotic Microcatheter Driver as part of the clinical study, “Embolization procedures in peripheral vasculature”.
Study principal investigator, Marc Sapoval and Gregory Amouyal performed the procedure at Hôpital Européen Georges Pompidou. The study case was a prostate artery embolization procedure for the treatment of benign prostatic hyperplasia.
The Magellan Robotic Microcatheter Driver is the latest design the company is seeking to add to the growing family of approved devices. The Magellan Microcatheter Driver’s design provides for robotic navigation and control of a wide variety of 3rd party microcatheters and expands the application of the Magellan Robotic System to a greater portion of many endovascular procedures.
“We are pleased to complete the world’s first clinical procedure using the Magellan Microcatheter Driver as part of this clinical study,” explained Sapoval. “Manual control of microcatheters and microwires can be challenging, particularly in tortuous anatomy. By utilising the Microcatheter Driver in conjunction with the Magellan 6F robotic catheter, we are enhancing the utility of the Magellan Robotic System and realising its potential in a pivotal aspect of embolization procedures.”
“Today’s announcement is an important milestone for Hansen Medical. Upon regulatory approval, the Magellan Robotic Microcatheter Driver will be an important expansion of our product line and represents a step forward in our goal toward vascular interventions that will eventually be performed 100% robotically,” said Cary Vance, president and CEO of Hansen Medical. “By advancing microcatheters with the Magellan System, we expect to add greater precision while continuing to provide physicians the benefit of reduced exposure to procedural radiation.”
The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guidewires during minimally-invasive, endovascular procedures. Magellan is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy.